Mersana Therapeutics Inc banner

Mersana Therapeutics Inc
NASDAQ:MRSN

Watchlist Manager
Mersana Therapeutics Inc Logo
Mersana Therapeutics Inc
NASDAQ:MRSN
Watchlist
Price: 29.08 USD 0.14%
Market Cap: $145.4m

Cash Flow Statement

Cash Flow Statement
Mersana Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(14)
(16)
(22)
(23)
(39)
(43)
(46)
(56)
(64)
(30)
(35)
(34)
(28)
(67)
(70)
(75)
(88)
(106)
(127)
(150)
(170)
(183)
(194)
(208)
(204)
(213)
(215)
(197)
(172)
(135)
(105)
(75)
(69)
(74)
(74)
(70)
Depreciation & Amortization
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
1
1
Stock-Based Compensation
1
1
1
1
1
2
3
3
4
4
5
5
5
5
6
6
7
10
13
16
18
20
21
21
22
22
24
22
21
19
17
17
16
15
12
9
Other Non-Cash Items
1
1
1
1
1
1
2
3
4
4
5
5
5
5
6
6
7
10
13
16
19
21
22
22
21
20
20
18
17
16
14
14
13
12
11
10
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
3
3
3
3
3
3
4
3
3
3
2
Change in Working Capital
44
4
8
3
(6)
(8)
(7)
2
4
(38)
(36)
(43)
(46)
(4)
(3)
(2)
5
15
14
18
10
40
40
145
133
121
107
(10)
(16)
(55)
(43)
(36)
(28)
(18)
(18)
(15)
Cash from Operating Activities
32
N/A
(11)
N/A
(12)
-7%
(19)
-52%
(43)
-131%
(49)
-15%
(51)
-4%
(50)
+1%
(55)
-10%
(63)
-13%
(65)
-4%
(71)
-9%
(68)
+5%
(64)
+5%
(66)
-3%
(70)
-6%
(75)
-7%
(80)
-8%
(99)
-23%
(115)
-16%
(140)
-22%
(121)
+14%
(131)
-9%
(41)
+69%
(49)
-22%
(70)
-43%
(87)
-24%
(188)
-115%
(169)
+10%
(173)
-2%
(133)
+23%
(95)
+28%
(82)
+13%
(79)
+4%
(80)
-1%
(74)
+7%
Investing Cash Flow
Capital Expenditures
(1)
(1)
(0)
(0)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(3)
(3)
(2)
(1)
(1)
(1)
(0)
0
0
0
Other Items
0
0
(44)
(86)
(98)
(75)
(1)
62
89
76
34
(29)
(27)
(18)
9
54
38
18
3
0
0
0
(90)
(106)
(151)
(148)
(63)
57
122
47
58
(18)
12
111
106
78
Cash from Investing Activities
(1)
N/A
(1)
-6%
(44)
-3 759%
(86)
-94%
(100)
-16%
(76)
+23%
(2)
+97%
60
N/A
87
+45%
74
-15%
32
-56%
(30)
N/A
(27)
+9%
(18)
+34%
9
N/A
54
+487%
37
-31%
17
-53%
2
-88%
(1)
N/A
(1)
+4%
(1)
-34%
(91)
-10 360%
(107)
-18%
(153)
-42%
(151)
+1%
(66)
+56%
54
N/A
120
+121%
46
-62%
57
+24%
(18)
N/A
11
N/A
111
+870%
106
-5%
78
-27%
Financing Cash Flow
Net Issuance of Common Stock
58
58
0
69
69
69
69
1
1
93
93
93
93
1
166
166
168
168
37
35
2
62
69
81
153
115
147
136
95
79
6
6
6
0
0
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
5
5
5
5
63
63
63
63
(0)
1
61
61
61
60
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(2)
(5)
(8)
(26)
Other
0
(1)
(2)
0
0
(2)
(0)
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
Cash from Financing Activities
58
N/A
58
-1%
(2)
N/A
69
N/A
69
N/A
69
+1%
71
+3%
1
-99%
1
+22%
93
+8 674%
98
+5%
98
0%
98
+0%
5
-94%
229
+4 133%
229
0%
230
+1%
231
+0%
36
-84%
37
+1%
64
+74%
124
+94%
130
+5%
140
+8%
153
+9%
114
-25%
147
+29%
136
-7%
95
-30%
79
-17%
6
-92%
6
+2%
4
-32%
(5)
N/A
(8)
-67%
(26)
-218%
Change in Cash
Net Change in Cash
89
N/A
45
-49%
(59)
N/A
(36)
+39%
(74)
-104%
(56)
+24%
18
N/A
11
-40%
33
+205%
105
+218%
65
-38%
(3)
N/A
3
N/A
(77)
N/A
172
N/A
213
+24%
193
-9%
168
-13%
(61)
N/A
(79)
-30%
(77)
+3%
2
N/A
(92)
N/A
(8)
+92%
(49)
-544%
(107)
-119%
(7)
+94%
2
N/A
46
+1 976%
(48)
N/A
(70)
-46%
(107)
-54%
(67)
+38%
27
N/A
18
-34%
(22)
N/A
Free Cash Flow
Free Cash Flow
31
N/A
(13)
N/A
(12)
+2%
(19)
-51%
(44)
-135%
(50)
-14%
(53)
-5%
(52)
+1%
(57)
-9%
(64)
-13%
(66)
-4%
(72)
-8%
(68)
+5%
(65)
+5%
(66)
-2%
(70)
-6%
(75)
-7%
(81)
-8%
(100)
-23%
(116)
-16%
(141)
-22%
(122)
+13%
(132)
-9%
(42)
+68%
(52)
-22%
(73)
-42%
(90)
-23%
(191)
-112%
(171)
+10%
(174)
-2%
(134)
+23%
(96)
+28%
(82)
+14%
(79)
+4%
(80)
-1%
(74)
+7%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett